| Patent | Date |
|---|
Dihydroisoquinoline-2(1h)-carboxamide And Related Compounds And Their Use In Treating Medical Conditions
App 20210139484 - Aicher; Thomas Daniel ; et al. | 2021-05-13 |
Indolinyl Sulfonamide And Related Compounds For Use As Agonists Of Rory And The Treatment Of Disease
App 20200207726 - VanHuis; Chad A. ; et al. | 2020-07-02 |
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
Grant 10,556,898 - Aicher , et al. Feb | 2020-02-11 |
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
Grant 10,532,088 - Glick , et al. Ja | 2020-01-14 |
Indazolyl-1,2,4-thiadiazolamines And Related Compounds For Inhibition Of Rho-associated Protein Kinase And The Treatment Of Dise
App 20190276447 - Aicher; Thomas D. ; et al. | 2019-09-12 |
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
Grant 10,377,768 - Aicher , et al. A | 2019-08-13 |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease
Grant 10,208,061 - Aicher , et al. Feb | 2019-02-19 |
Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
Grant 10,112,935 - Aicher , et al. October 30, 2 | 2018-10-30 |
Tetrahydro[1,8]naphthyridine Sulfonamide And Related Compounds for Use as Agonists of RORy and the Treatment of Disease
App 20180179224 - Aicher; Thomas D. ; et al. | 2018-06-28 |
Indazolyl Thiadiazolamines And Related Compounds For Inhibition Of Rho-associated Protein Kinase And The Treatment Of Disease
App 20180093978 - Aicher; Thomas Daniel ; et al. | 2018-04-05 |
Indazole guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof
Grant 9,920,012 - Hurd , et al. March 20, 2 | 2018-03-20 |
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
App 20170313722 - Aicher; Thomas D. ; et al. | 2017-11-02 |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease
Grant 9,802,958 - Aicher , et al. October 31, 2 | 2017-10-31 |
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease
Grant 9,657,033 - Aicher , et al. May 23, 2 | 2017-05-23 |
Saturated acyl guanidine for inhibition of F.sub.1F.sub.0-ATPase
Grant 9,580,391 - Hurd , et al. February 28, 2 | 2017-02-28 |
Adoptive Cellular Therapy Using an Agonist of Retinoic Acid Receptor-Related Orphan Receptor Gamma & Related Therapeutic Methods
App 20170007686 - Glick; Gary D. ; et al. | 2017-01-12 |
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease
Grant 9,512,111 - Glick , et al. December 6, 2 | 2016-12-06 |
Tetrahydro[1,8]naphthyridine Sulfonamide And Related Compounds for Use as Agonists of RORy and the Treatment of Disease
App 20160318951 - Aicher; Thomas D. ; et al. | 2016-11-03 |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease
Grant 9,394,315 - Aicher , et al. July 19, 2 | 2016-07-19 |
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease
Grant 9,266,827 - Aicher , et al. February 23, 2 | 2016-02-23 |
Heterocyclic guanidine F.sub.1F.sub.0-atpase inhibitors and therapeutic uses thereof
Grant 9,221,814 - Hurd , et al. December 29, 2 | 2015-12-29 |
Cycloalkyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof
Grant 9,169,199 - Hurd , et al. October 27, 2 | 2015-10-27 |
Indazole Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20150152063 - Hurd; Alexander R. ; et al. | 2015-06-04 |
Heterocyclic Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20150148373 - Hurd; Alexander R. ; et al. | 2015-05-28 |
Tetrahydro[1,8]naphthyridine Sulfonamide and Related Compounds for Use as Agonists of RORy and the Treatment of Disease
App 20150133437 - Aicher; Thomas D. ; et al. | 2015-05-14 |
BICYCLIC SULFONE COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
App 20150126493 - Aicher; Thomas D. ; et al. | 2015-05-07 |
Saturated Acyl Guanidine For Inhibition Of F1f0-atpase
App 20150119439 - Hurd; Alexander R. ; et al. | 2015-04-30 |
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
App 20150111877 - Aicher; Thomas D. ; et al. | 2015-04-23 |
N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
App 20140088094 - Glick; Gary D. ; et al. | 2014-03-27 |
Cycloalkyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20130331392 - Hurd; Alexander R. ; et al. | 2013-12-12 |
Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
Grant 6,982,260 - Barvian , et al. January 3, 2 | 2006-01-03 |
| 